Parotid-sparing radiotherapy: does it really reduce xerostomia?

Area of Science:

• Radiation Oncology
• Head and Neck Cancer Treatment
• Quality of Life Research

Background:

• Parotid-sparing radiotherapy (PSRT) was implemented in 2000 for head and neck cancer patients requiring bilateral upper-neck irradiation.
• Conventional radiotherapy techniques often lead to significant xerostomia (dry mouth).

Purpose of the Study:

• To compare the subjective experience of xerostomia in patients treated with PSRT versus conventional radiotherapy.
• To evaluate the long-term quality of life impact of different radiotherapy techniques on xerostomia.

Main Methods:

• A retrospective study comparing 38 patients treated with PSRT (mean parotid dose ≤33 Gy) and 44 patients treated with conventional radiotherapy (minimum parotid dose ≥40 Gy).
• Xerostomia was assessed using a validated 6-question questionnaire (0-10 scale, lower scores indicate less difficulty).
• Patients were interviewed at least 6 months post-treatment and required to be recurrence-free.

Main Results:

• Patients treated with PSRT reported a significantly lower mean xerostomia score (4.20) compared to those receiving conventional radiotherapy (5.86) (P < 0.001).
• Individual question scores related to xerostomia were also significantly better in the PSRT group.
• The study included patients with oropharyngeal and nasopharyngeal cancers.

Conclusions:

• PSRT demonstrates a significant benefit in reducing long-term xerostomia.
• These findings suggest improved quality of life for head and neck cancer patients treated with parotid-sparing radiotherapy compared to conventional methods.